Rainer Krähenmann, Dr. med. FMH Psychiatry and Psychotherapy, trained as a medical doctor at the University of Zürich and is currently a senior clinical psychiatrist and research fellow at the Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital, University of Zürich. Krähenmann began his scientific career in 2010, when he joined Prof. Dr. med. Franz X. Vollenweider’s research lab. Since then, he has lead several psychedelic studies on the neurobiological and behavioural effects of psychedelics in humans. Krähenmann is especially interested in exploring new treatment options for psychiatric patients.
Krähenmann will speak about the recent randomized, double-blind, placebo-controlled study into the effects of LSD on cognition. Krähenmann postulates that when combined with guided mental imagery psychedelics may enhance and deepen psychotherapeutic processes. His recent data show that psychedelics acutely shift cognition from a rational, reality-bound, secondary process-driven mode towards a more irrational, hyper-associative, primary process-driven mode which is highly similar to dreaming. Relevance for psychedelic psychotherapy and implications for treatment of psychiatric disorders such as depression and anxiety will be discussed.